<DOC>
	<DOCNO>NCT00334633</DOCNO>
	<brief_summary>We try determine treatment bacterial vaginosis tinidazole well treatment metronidazole</brief_summary>
	<brief_title>Treatment Bacterial Vaginosis ( BV ) With Tinidazole</brief_title>
	<detailed_description>Bacterial vaginosis ( BV ) prevalent cause symptomatic vaginal discharge U.S. associate complication include preterm delivery infant , pelvic inflammatory disease ( PID ) , urinary tract infection ( UTI ) acquisition/transmission sexually transmit disease ( STDs ) include human immunodeficiency virus ( HIV ) . Control BV advocate mean decrease prevalence complication . However , etiology BV remain unknown current treatment regimen inadequate term initial cure recurrence rate . Although currently license U.S. , tinidazole antimicrobial relate metronidazole show promise treatment BV European study widely use worldwide treatment trichomoniasis include infection resistant metronidazole . We hypothesize quality tinidazole longer half-life seemingly superior side effect profile compare oral metronidazole result efficacious drug treatment BV currently available option . The specific aim project : 1 . To compare efficacy two different dos tinidazole oral metronidazole initial treatment symptomatic BV well short-term recurrence rate 2 . To compare side effect profile tinidazole versus metronidazole treatment BV 3 . To compare drug level tinidazole metronidazole vaginal secretion correlate microbiologic cure BV well rate recurrence .</detailed_description>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Tinidazole</mesh_term>
	<criteria>Women least 18 year age Have symptoms vaginal odor or/discharge Meet clinical ( Amsel ) criteria BV Willing participate research Presence another vaginal infection STD Allergy metronidazole Pregnant nursing Use oral intravaginal antibiotic within past 2 week HIV chronic disease Inability keep return appointment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>bacterial vaginosis</keyword>
	<keyword>tinidazole</keyword>
</DOC>